https://pharminent.com/rare-disease-gene-therapy/rare-disease-gene-therapy-digest-july-30-2026/ 2026-07-30T22:11:13Z Pharminent en Rare Disease & Gene Therapy Digest • July 30, 2026 2026-07-30T22:11:11Z Blog https://pharminent.com/amgens-repatha-wins-positive-chmp-opinion-for-preventing-first-heart-attacks-and-strokes/ 2026-07-30T20:08:59Z Pharminent en Amgen's Repatha Wins Positive CHMP Opinion for Preventing First Heart Attacks and Strokes 2026-07-30T20:08:55Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-july-30-2026/ 2026-07-30T16:21:19Z Pharminent en Strategic News Watch • July 30, 2026 2026-07-30T16:21:16Z Blog https://pharminent.com/neuromarket-pulse/neuromarket-pulse-weekly-neuroscience-competitive-intelligence-july-29-2026/ 2026-07-30T14:49:42Z Pharminent en NeuroMarket Pulse • Weekly Neuroscience Competitive Intelligence • July 29, 2026 2026-07-30T14:49:40Z Blog https://pharminent.com/gsk-cambridge-move-signals-shift-in-drug-scale-up-strategy/ 2026-07-29T20:55:26Z Pharminent en GSK Cambridge Move Signals Shift in Drug Scale-Up Strategy 2026-07-29T20:37:33Z Blog https://pharminent.com/manufacturing-intelligence/manufacturing-intelligence-weekly-digest-july-29-2026/ 2026-07-29T20:17:48Z Pharminent en Manufacturing Intelligence • Weekly Digest • July 29, 2026 2026-07-29T20:17:46Z Blog https://pharminent.com/vertex-abcellera-partner-on-next-generation-t-cell-engagers-for-autoimmune-disease/ 2026-07-29T20:38:12Z Pharminent en Vertex, AbCellera Partner on Next-Generation T-Cell Engagers for Autoimmune Disease 2026-07-29T20:01:18Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-july-29-2026/ 2026-07-29T19:30:45Z Pharminent en Strategic News Watch • July 29, 2026 2026-07-29T15:42:39Z Blog https://pharminent.com/leqembi-sales-grow-again-after-subcutaneous-approvals/ 2026-07-30T17:58:38Z Pharminent en Leqembi sales grow again after subcutaneous approvals 2026-07-29T11:53:51Z Blog https://pharminent.com/eisai-and-core-biomedicine-agree-on-global-licence-for-oncology-pipeline/ 2026-07-30T17:56:09Z Pharminent en Eisai and CORE Biomedicine agree on global licence for oncology pipeline 2026-07-29T08:37:33Z Blog